openPR Logo
Press release

What’s driving the Blockbuster Drugs Market growth? With Top Profiled – AbbVie , Celgene , Gilead Science , Merck , Roche , Bristol Myers Squibb , Pfizer , Johnson & Johnson , Amgen , Biogen , Bayer , Regeneron Pharmaceuticals , Novo Nordisk

06-04-2019 01:36 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: marketstudyreport.com

/ PR Agency: marketstudyreport
What’s driving the Blockbuster Drugs Market growth? With Top

MarketStudyReport.com adds Blockbuster Drugs Market Report provides an analytical assessment of the prime challenges faced by this Market currently and in the coming years, which helps Market participants in understanding the problems they may face while operating in this Market over a longer period of time.

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/1374385/?utm_source=openpr.com&utm_medium=Deepak

Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for global blockbuster drugs market. The report includes historic data from 2015 to 2017 and forecasts until 2025.

The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
1) AbbVie
2) Celgene
3) Gilead Science
4) Merck
5) Roche
6) Bristol Myers Squibb
7) Pfizer
8) Johnson & Johnson
9) Amgen
10) Biogen
11) Bayer
12) Regeneron Pharmaceuticals
13) Novo Nordisk
14) Allergan
15) Alexion Pharmaceuticals
16) GlaxoSmithKline
17) Novartis
18) Eli Lilly and Company
19) Astrazeneca
20) Incyte Corporation
21) Boehringer Ingelheim
22) Astellas Pharma

The report contains a granular analysis of the present industry situations, market demands, reveals facts on the market size, revenues and provides forecasts through 2025. The report provides clear insight into current and future developments of the global blockbuster drugs market. The report explores detailed analysis of top 50 drugs market assessment globally from 2015 to 2017 and forecasts to 2025. The report also details the latest information about the global research & development spend by pharma & biotech companies

Additionally, the report includes assessment of most valuable drugs research and development projects insights by phase and market value. Key trends in terms of collaboration, merger & acquisition, partnerships and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the global blockbuster drugs market.

The report concludes with the profiles of major players in the global blockbuster drugs market. The key market players are evaluated on various parameters such as business overview and recent development.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/1374385/?utm_source=openpr.com&utm_medium=Deepak

Top 50 Blockbuster Drugs Covered Under This Report Are:
1) Humira
2) Imbruvica
3) Revlimid
4) Genvoya
5) Truvada
6) Harvoni
7) Epclusa
8) Keytruda
9) Januvia/Janumet
10) Herceptin
11) Avastin
12) MabThera/Rituxan
13) Perjeta
14) Opdivo
15) Eliquis
16) Orencia
17) Sprycel
18) Lyrica
19) Ibrance
20) Simponi
21) Stelara
22) Zytiga
23) Invega Sustenna
24) Xarelto
25) Enbrel
26) Tagrisso
27) Tecfidera
28) Eylea
29) Victoza
30) Botox
31) Soliris
32) Triumeq
33) Seretide/Advair
34) Gilenya
35) Cosentyx
36) Trulicity
37) Cialis
38) Humalog
39) Symbicort
40) Zepatier
41) Pomalyst/Imnovid
42) Darzalex
43) Prolia/Xgeva
44) Ocrevus
45) Xtandi
46) Tivicay
47) Jakafi/Jakavi
48) Jardiance
49) Trajenta / Jentadueto
50) Relvar/Breo Ellipta

The Latest Industry Data Included in this Report:

Global Top 50 Blockbuster Drugs Market Size & Analysis (2015 2025)
Global Top 50 Blockbuster Drugs Market Share & Y o Y Growth (%), 2015 2025
Global Top 50 Blockbuster Drugs Market Assessment & Opportunity, (2015 2025)
Most Valuable Drugs Research and Development (R&D) Projects Insights by Phase and Market Value
Global Research & Development (R&D) Spend by Pharma & Biotech Companies (2015 2025)
Major Deals (Mergers, Acquisitions, Key Agreements, Partnerships & Collaborations)
Key Market Drivers and Inhibitors of the Global Blockbuster Drugs Market
Major Companies Analysis

The Answers to the Following Key Questions can be found in the Report:

What is the size of the global top 50 blockbuster drugs market during 2015 -2025
What will be the revenue generated by each drug during the forecast period
Which major drugs provides highest market share
How are the overall market and major drugs growing
What are the key drivers and inhibitors in the current market
What will be the impact of drivers and inhibitors in the future
How is the market predicted to develop in the future
Who are the key players in this market space

1. Executive Summary
2. Global Top 50 Blockbuster Drugs Market Size& Analysis (2015 2025)
3. Global Top 50 Blockbuster Drugs Market Share & Y o Y Growth (%), 2015 2025
4. Key Drivers and Inhibitors of the Global Blockbuster Drugs Market
4.1 Market Drivers
4.2 Market Inhibitors
5. Global Top 50 Blockbuster Drugs Market Assessment & Opportunity, (2015 2025)
5.1 Humira (Adalimumab)
5.2 Imbruvica (Ibrutinib)
5.3 Revlimid (Lenalidomide)
5.4 Pomalyst/Imnovid (Pomalidomide)
5.5 Genvoya (Cobicistat; Elvitegravir; Emtricitabine; Tenofovir Alafenamide fumarate)
5.6 Truvada (Emtricitabine / Tenofovir)
5.7 Harvoni (Ledipasvir / Sofosbuvir)
5.8 Epclusa (Sofosbuvir / Velpatasvir)
5.9 Keytruda (Pembrolizumab)
5.10 Januvia/Janumet (Sitagliptin / Metformin)
5.11 Herceptin (Trastuzumab)
5.12 Avastin (Bevacizumab)
5.13 MabThera/Rituxan (Rituximab)
5.14 Perjeta (Pertuzumab)
5.15 Opdivo (Nivolumab)
5.16 Eliquis (Apixaban)
5.17 Orencia (Abatacept)
5.18 Sprycel (Dasatinib)
5.19 Lyrica (Pregabalin)
5.20 Ibrance (Palbociclib)
5.21 Simponi (Golimumab)
5.22 Stelara (Ustekinumab)
5.23 Zytiga (Abiraterone acetate)
5.24 Invega Sustenna (Paliperidone)
5.25 Xarelto (Rivaroxaban)
5.26 Tagrisso (Osimertinib)
5.27 Enbrel (Etanercept)
5.28 Eylea (Aflibercept)
5.29 Victoza (Liraglutide)
5.30 Botox (Botulinum toxin)
5.31 Soliris (Eculizumab)
5.32 Triumeq (Abacavir / Dolutegravir / Lamivudine)
5.33 Seretide/Advair (Fluticasone propionate / Salmeterol)
5.34 Gilenya (Fingolimod)
5.35 Cosentyx (Secukinumab)
5.36 Trulicity (Dulaglutide)
5.37 Humalog (Insulin Lispro)
5.38 Cialis (Tadalafil)
5.39 Symbicort (Budesonide / Formoterol)
5.40 Zapatier (Elbasvir / Grazoprevir)
5.41 Tecfidera (Dimethyl fumarate)
5.42 Darzalex (Daratumumab)
5.43 Prolia/Xgeva (Denosumab)
5.44 Ocrevus (Ocrelizumab)
5.45 Xtandi (Enzalutamide)
5.46 Tivicay (Dolutegravir)
5.47 Jakafi/Jakavi (Ruxolitinib Phosphate)
5.48 Jardiance (Empagliflozin)
5.49 Trajenta/Jentadueto (Linagliptin)
5.50 Relvar/Breo Ellipta (Fluticasone furoate / Vilanterol)
6. Most Valuable Drugs Research and Development (R&D) Projects Insights by Phase and Market Value
7. Global Research & Development (R&D) Spend by Pharma & Biotech Companies (2015 2025)
8. Major Deals (Mergers, Acquisitions, Key Agreements, Partnerships & Collaborations)
9. Key Companies Analysis
9.1 AbbVie
9.1.1 Business Overview
9.1.2 Recent Development
9.2 Celgene
9.2.1 Business Overview
9.2.2 Recent Development
9.3 Gilead Science
9.3.1 Business Overview
9.3.2 Recent Development
9.4 Merck
9.4.1 Business Overview
9.4.2 Recent Development
9.5 Roche
9.5.1 Business Overview
9.5.2 Recent Development
9.6 Bristol Myers Squibb
9.6.1 Business Overview
9.6.2 Recent Development
9.7 Pfizer
9.7.1 Business Overview
9.7.2 Recent Development
9.8 Johnson & Johnson
9.8.1 Business Overview
9.8.2 Recent Development
9.9 Amgen
9.9.1 Business Overview
9.9.2 Recent Development
9.10 Biogen
9.10.1 Business Overview
9.10.2 Recent Development
9.11 Bayer
9.11.1 Business Overview
9.11.2 Recent Development
9.12 Regeneron Pharmaceuticals
9.12.1 Business Overview
9.12.2 Recent Development
9.13 Novo Nordisk
9.13.1 Business Overview
9.13.2 Recent Development
9.14 Allergan
9.14.1 Business Overview
9.14.2 Recent Development
9.15 Alexion pharmaceuticals
9.15.1 Business Overview
9.15.2 Recent Development
9.16 GlaxoSmithKline
9.16.1 Business Overview
9.16.2 Recent Development
9.17 Novartis
9.17.1 Business Overview
9.17.2 Recent Development
9.18 Eli Lilly and Company
9.18.1 Business Overview
9.18.2 Recent Development
9.19 Astrazeneca
9.19.1 Business Overview
9.19.2 Recent Development
9.20 Incyte Corporation
9.20.1 Business Overview
9.20.2 Recent Development
9.21 Boehringer Ingelheim
9.21.1 Business Overview
9.21.2 Recent Development
9.22 Astellas Pharma
9.22.1 Business Overview
9.22.2 Recent Development

More Details on this Report: https://www.marketstudyreport.com/reports/global-blockbuster-drugs-market-2015-2025-top-50-drugs-analysis-deal-trends-players-and-forecasts/?utm_source=openpr.com&utm_medium=Deepak

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:

Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: www.marketstudyreport.com
Blog: www.marketstudyreport.com/blog

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release What’s driving the Blockbuster Drugs Market growth? With Top Profiled – AbbVie , Celgene , Gilead Science , Merck , Roche , Bristol Myers Squibb , Pfizer , Johnson & Johnson , Amgen , Biogen , Bayer , Regeneron Pharmaceuticals , Novo Nordisk here

News-ID: 1763077 • Views:

More Releases from marketstudyreport.com

Load Bank Market Growth Prospectus by 2028 - Business Opportunities by ASCO Power Technologies (Schneider Electric), Simplex, Shenzhen Sikes, Pite Tech
Load Bank Market Growth Prospectus by 2028 - Business Opportunities by ASCO Powe …
A concise assortment of data on the 'Load Bank Market' offers an exhaustive study targeting current market trends influencing the business across assorted regions. Significant details related to market size, market share, applications, and statistics are put together to convey an ensemble prediction of the industry. The research further focuses on comprehensive competitor analysis in addition to highlighting growth strategies embraced by market leaders. Load Bank Market Size was estimated
Agriculture Equipment Market is Expected to Reach USD 161640 Million by 2028 - John Deere, CNH Industrial, Kubota, AGCO, Claas, Yanmar, Mahindra, LOVOL
Agriculture Equipment Market is Expected to Reach USD 161640 Million by 2028 - J …
Global Agriculture Equipment Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of the market with the geographical landscape, demand, remuneration scale, and growth of this vertical have also been included in this report. Global Agriculture Equipment Market Size was estimated at USD 114110 million in 2021 and is projected to reach USD 161640 million by 2028, exhibiting a CAGR of
Electric Vehicle Market Size to grow at a CAGR of 23.5% through 2028| Tesla Inc., Volkswagen AG, SAIC Motors, BYD Auto Co. Ltd., BMW Group, Nissan Motor Co. Ltd., Hyundai Group
Electric Vehicle Market Size to grow at a CAGR of 23.5% through 2028| Tesla Inc. …
Global Electric Vehicle Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of market with the geographical landscape, demand, remuneration scale, and growth of this vertical have also been included in this report. The electric vehicles (EVs) market is estimated to witness a robust growth rate of 23.5% during the period 2019-2028. The operation is done to stop ligament tears and
Fuel Cell Air Compressor Market is Expected to Reach USD 512.3 Million by 2028 - Garrett Motion, Hanon Systems, UQM Technologies, FISCHER Fuel Cell Compressor
Fuel Cell Air Compressor Market is Expected to Reach USD 512.3 Million by 2028 - …
Global Fuel Cell Air Compressor Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of market with the geographical landscape, demand, remuneration scale, and growth of this vertical have also been included in this report. Global Fuel Cell Air Compressor Market Size was estimated at USD 215.1 million in 2021 and is projected to reach USD 512.3 million by 2028, exhibiting

All 5 Releases


More Releases for Business

Business-to-Business eCommerce Market is Going to Boom | Alibaba, Amazon Busines …
The Global Business-to-Business eCommerce Market report, spanning over 135+ pages, provides a comprehensive overview of the product/industry scope and outlines the market outlook and status from 2024 to 2032. The study is segmented by key regions driving market growth. Currently, the market is expanding its presence, with notable contributions from key players such as Alibaba, Amazon Business, eBay Business, IndiaMART, ThomasNet, Global Sources, SAP Ariba, Salesforce, Shopify Plus, BigCommerce, Oracle
Factors Influencing Global Business Broker Service Market through 2023 and Beyon …
The worldwide "Business Broker Service Market" 2023 Research Report presents a professional and complete analysis of the Global Business Broker Service Market in the current situation. This report includes development plans and policies along with Business Broker Service manufacturing processes and price structures. the reports 2023 research report offers an analytical view of the industry by studying different factors like Business Broker Service Market growth, consumption volume, Market Size, Revenue,
Business Consulting Company, Business Consulting Firm, Business Consulting Servi …
The market research is an essential portion of any business strategy and primarily comprises of the data collecting about the markets and consumers in those markets. In recent’s globalized business surroundings, effective market research is a critical portion of any business’s efforts to compete successfully. At Ken Research, the market research services support businesses identify growth opportunities and form a competitive strategy reliant on the deep understanding of consumers and
Business to Business Media Market 2019 Business Scenario – Bloomberg, IBM, Ora …
A new Profession Intelligence Report released by Stats and Reports with the title Global Business to Business Media Market "can grow into the most important market in the world that has played an important role in making progressive impacts on the global economy. Global Business to Business Media Market Report presents a dynamic vision to conclude and research market size, market hope and competitive environment. The study is derived from
Business Alliance Market Growing Dynamically with Leading Top Key Players like B …
A business alliance is an agreement between businesses, usually motivated by cost reduction and improved service for the customer. Alliances are often bounded by a single agreement with equitable risk and opportunity share for all parties involved and are typically managed by an integrated project team. An example of this is code sharing in airline alliances. The Global Business Alliance Market 2019 research provides a basic overview of the industry including
Global Interferon Market Business Growth, Business Opportunities, Business Outlo …
Albany, NY, USA / 16 Oct 2018: - A New fresh research report presented by KD Market Insights provides a detailed analysis of “Global Interferon Market Size, Trends, Opportunity and Forecast to 2023” research report will include all the major trends and technologies that play an important role in market growth in the predicted span of 6 years. It also presents the overview of industry players, advantages, challenges the business